Nutrition Support on Outcomes and Cost-effectiveness for Patients at Risk

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorPeking Union Medical College

About this trial

1. The aim of this large scale study to survey the prevalence of nutritional risk and malnutrition in China,Europe and USA. 2. The impact of nutritional support for the patients at nutritional risk on clinical outcomes and cost-effectiveness

Already get the approval by Ethics Committee of Peking Union medical college and Johns Hopkins Hospital.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

patients be in hospital overnight

diagnoses according to the protocol of cohort study for cost effectiveness

Disqualifiers

patients admitting from emergency department

patients who undergone operation before second morning of hospitalization

patients who dose not give Informed Consents

Trial population

Continuing sampling in 6 clinical Departments of large, middle \& small size hospitals in 15 large cities from West, Middle \& East China. Also, data from Denmark and USA will be collected and analysed.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

2,000 Participants
are grouped into 2 trial groups
Group A: Nutrition support
Group B: Without nutritional support

Trial outcomes

Primary outcomes

1

Infectious complication

A infectious complication was defined as as the presence of recognized pathogens in body tissues that normally are sterile, confirmed by the results of culture and supported by clinical, radiologic or hematologic evidence of infection

Time frame
Observation will be carried from admitting end until discharge

Secondary outcomes

1

cost effectiveness

The cost effectiveness analysis was performed from the payers' perspective.The percentage of infectious complication-free patients was used to measure the effectiveness. The total cost was considered to contain 3 items in our study. The first item was the cost of nutrition support, including nutrition solutions, nursing, physician, and other staff supervision of nutrition support preparation, administration, and catheter placement and maintenance. The second item was the cost of the infectious complication.The third item was 'other costs' associated with the hospital admission, calculated from the total costs from which the cost of nutrition support and infectious complications were subtracted. The incremental cost-effectiveness ratio (ICER) was calculated by dividing the costs difference between the nutrition support cohort and no-nutrition support cohort by their difference in effectiveness.

Time frame
Observation will be carried from admitting end until discharge

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.